U.S. markets close in 5 hours 29 minutes
  • S&P 500

    4,272.15
    -8.00 (-0.19%)
     
  • Dow 30

    33,755.20
    -5.85 (-0.02%)
     
  • Nasdaq

    13,027.57
    -19.61 (-0.15%)
     
  • Russell 2000

    1,999.85
    -16.77 (-0.83%)
     
  • Crude Oil

    87.85
    -4.24 (-4.60%)
     
  • Gold

    1,791.50
    -24.00 (-1.32%)
     
  • Silver

    20.08
    -0.62 (-2.99%)
     
  • EUR/USD

    1.0197
    -0.0061 (-0.59%)
     
  • 10-Yr Bond

    2.7750
    -0.0740 (-2.60%)
     
  • GBP/USD

    1.2088
    -0.0051 (-0.42%)
     
  • USD/JPY

    132.9390
    -0.5410 (-0.41%)
     
  • BTC-USD

    24,132.41
    -380.05 (-1.55%)
     
  • CMC Crypto 200

    573.28
    -17.48 (-2.96%)
     
  • FTSE 100

    7,493.84
    -7.05 (-0.09%)
     
  • Nikkei 225

    28,871.78
    +324.80 (+1.14%)
     

BioNTech stock falls after CureVac files suit, saying COVID vaccine infringes patents

·1 min read
BioNTech stock falls after CureVac files suit, saying COVID vaccine infringes patents
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Shares of BioNTech SE fell 0.9% in premarket trading Tuesday, after CureVac N.V. filed in Germany a patent infringement suit against the biotechnology company. CureVac said there were certain of its patents that were utilized in the manufacture and sale of BioNTech and Pfizer Inc.'s COVID-19 vaccine, Comirnaty. CureVac said while it doesn't seek an injunction, and won't take legal action to impede the production or sale of Comirnaty, it is seeking "fair compensation" for infringement of its pate